Skip to main content
Clinical Trials/CTRI/2024/02/063171
CTRI/2024/02/063171
Not yet recruiting
Phase 2/3

Does rTMS Repetitive transcranial magnetic stimulation improve the outcome of in vitro fertilization in infertile women with moderate to severe depression

AIIMS Delhi1 site in 1 country40 target enrollmentStarted: February 26, 2024Last updated:

Overview

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
AIIMS Delhi
Enrollment
40
Locations
1
Primary Endpoint
Effect of rTMS on the clinical pregnancy rate in infertile women with depression undergoing IVF-Fresh ET

Overview

Brief Summary

This study is a pilot randomized, parallel group, placebo controlled trial studying the effect of rTMS (Repetitive transcranial magnetic stimulation) on the reproductive outcome in 40 infertile women with moderate to severe depression undergoing IVF cycles at ART centre, Department of Obstetrics and Gynaecology. The primary outcome measures the effect of rTMS on the clinical pregnancy rate in infertile women with depression undergoing IVF-Fresh ET cycles at 8 weeks. The secondary outcomes will be to assess depression measured using HAM-D questionnaire at 3 weeks, serum cortisol and BDNF levels at 3 weeks, oocyte and embryo quality at 6 weeks and  implantation success by measuring Beta HCG level at 7 weeks.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
21.00 Year(s) to 35.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Women undergoing IVF at ART center & willing to participate
  • Moderate to severe depression.

Exclusion Criteria

  • Comorbid psychiatric illness Substance abuse including nicotine Any other contraindication for rTMS Women with moderate to severe depression opting for pharmacotherapy Donor Recipient cycles Severe OATS (Oligoasthenoteratozoospermia) Oncofertility Hyper-responders like PCOS undergoing segmented Embryo Transfer.

Outcomes

Primary Outcomes

Effect of rTMS on the clinical pregnancy rate in infertile women with depression undergoing IVF-Fresh ET

Time Frame: 8 weeks

Secondary Outcomes

  • To assess depression measured using HAM-D questionnaire pre and post rTMS(3 weeks)
  • To assess the biochemical levels (Cortisol, BDNF) pre and post rTMS(3 weeks)
  • Oocyte and Embryo quality(6 weeks)
  • Implantation success by measuring Beta HCG levels(7 weeks)

Investigators

Sponsor
AIIMS Delhi
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Kataru Nikitha

AIIMS, New Delhi

Study Sites (1)

Loading locations...

Similar Trials